Polpharma in the news

Polpharma is growing and exploring acquisition opportunities to expand its pharmaceutical business.

The Polish Patent Office invalidated AstraZeneca's dapagliflozin patent, enabling generic versions like Polpharma's to enter the market and be reimbursed.

Polpharma Biologics secured nearly 17 million EUR in EU funding from PARP to build a research and production line for biological drug substances in Gdańsk.

Seven major companies, including Polpharma, have launched the "Power Age" initiative to foster generational diversity and collaboration in the workplace amidst demographic changes and technological advancements.

Polpharma Santo has started exporting Kazakhstan-made Sitagliptin 100 mg, a type 2 diabetes treatment, to the EU, following years of preparation and achieving EU GMP certification.

Aflofarm, USP Zdrowie, and Polpharma were the top three most mediatized pharmaceutical brands in July, with Aflofarm leading due to extensive advertising.

Aflofarm, USP Zdrowie, and Polpharma led the pharmaceutical industry in media visibility in July, with Aflofarm dominating advertising spend and reach.

Polpharma ranked first in Poland's Universum Most Attractive Employers 2026 in Natural Sciences, based on student evaluations.

Polpharma secured first place in the Universum Most Attractive Employers 2026 ranking for Natural Sciences in Poland, based on student votes.

Aflofarm, USP Zdrowie, and Polpharma were the most mediatized pharmaceutical brands in July, with Aflofarm leading in advertising expenditure.

Aflofarm, USP Zdrowie, and Polpharma were the most mediatized pharmaceutical brands in July, with Aflofarm leading in advertising expenditure.

Takeda has initiated legal action against Polpharma regarding its Entyvio biosimilar in both the US and Europe.

Takeda has filed a patent infringement lawsuit against Polpharma in the US over Polpharma's vedolizumab biosimilar, PB016, seeking to prevent its market entry.

A communication specialist with a decade of experience at Ringier Axel Springer Polska has transitioned to Polpharma, bringing her expertise in internal communications and employer branding.

Justyna Gościńska-Bociong is now the Head of PR and Media Relations at Polpharma Group, responsible for corporate communication and reputation management.

Justyna Gościńska-Bociong has been appointed as the press spokesperson for the Polpharma Group, overseeing corporate communications, M&A, and reputational risk.

Justyna Gościńska-Bociong has been appointed as the Head of PR and Media Relations for Polpharma Group to strengthen its corporate communication and reputation.

Polpharma's revenues in Poland consistently grew from 2014 to 2025, reaching *** billion zloty.

Polpharma acquired Romanian pharmaceutical company Biofarm for 270 million euros, expanding its presence in Central and Eastern Europe.

Polpharma, a Polish pharmaceutical group, acquired a majority stake in Biofarm, a Romanian pharmaceutical manufacturer, with assistance from PwC Romania.